Related Experiment Video
Updated: Feb 5, 2026

Cefoperazone-treated Mouse Model of Clinically-relevant Clostridium difficile Strain R20291
Published on: December 10, 2016
Indomethacin increases severity of Clostridium difficile infection in mouse model
Juan Muñoz-Miralles1,2, Bruno C Trindade3, Pablo Castro-Córdova1,2
1Millennium Nucleus in the Biology of Intestinal Microbiota, Facultad de Ciencias de la Vida, Universidad Andrés Bello, 8370186 Santiago, Chile.
Aim:
To evaluate the effect on the nonsteroidal anti-inflammatory drug indomethacin on Clostridium difficile infection (CDI) severity.
Materials & Methods:
Indomethacin was administered in two different mouse models of antibiotic-associated CDI in two different facilities, using a low and high dose of indomethacin.
Results:
Indomethacin administration caused weight loss, increased the signs of severe infection and worsened histopathological damage, leading to 100% mortality during CDI. Indomethacin-treated, antibiotic-exposed mice infected with C. difficile had enhanced intestinal inflammation with increased expression of KC, IL-1β and IL-22 compared with infected mice unexposed to indomethacin.
Conclusion:
These results demonstrate a negative impact of nonsteroidal anti-inflammatory drugs on antibiotic-associated CDI in mice and suggest that targeting the synthesis or signaling of prostaglandins might be an approach to ameliorating the severity of CDI.
Insights
The nonsteroidal anti-inflammatory drug indomethacin worsened Clostridium difficile infection (CDI) severity in mice, causing increased mortality and inflammation. Targeting prostaglandins may help reduce CDI severity.
Area of Science:
- Microbiology and Immunology
- Pharmacology
Background:
- Clostridium difficile infection (CDI) is a significant healthcare-associated infection.
- Nonsteroidal anti-inflammatory drugs (NSAIDs) are commonly used medications with potential effects on inflammatory processes.
Purpose of the Study:
- To investigate the impact of indomethacin, an NSAID, on the severity of antibiotic-associated Clostridium difficile infection (CDI) in a mouse model.
Main Methods:
- Two mouse models of antibiotic-associated CDI were utilized across two facilities.
- Mice were administered varying doses (low and high) of indomethacin.
- Outcomes assessed included weight loss, clinical signs of infection, histopathological damage, mortality, and intestinal inflammatory markers (KC, IL-1β, IL-22).
Main Results:
- Indomethacin administration led to significant weight loss, exacerbated signs of severe infection, and increased histopathological damage in CDI models.
- A 100% mortality rate was observed in indomethacin-treated mice during CDI.
- Indomethacin-treated mice exhibited enhanced intestinal inflammation, with elevated expression of KC, IL-1β, and IL-22 compared to controls.
Conclusions:
- NSAID administration, specifically indomethacin, negatively impacts antibiotic-associated CDI severity in mice.
- Targeting prostaglandin synthesis or signaling pathways presents a potential therapeutic strategy for ameliorating CDI severity.
More Related Videos
Related Concept Videos
Increasing Function
Increased Body Temperature
Increased pulse rate
Many factors can elevate the risk of developing tachycardia. These include advanced age, a family history of arrhythmias, and an...
Infection
The chain begins with pathogens: bacteria, viruses, fungi, prions, or parasites such as protozoa helminths. These can be present on the skin as transient or resident flora, or they can be acquired from the environment. Identifying and treating the type of infection and...
Mouse Models of Cancer Study
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
Stages of Infection

